ONCE stock forecast
Our latest prediction for Spark Therapeutics, Inc.'s stock price was made on the Feb. 27, 2019 when the stock price was at 113.40$.
In the short term (2weeks), ONCE's stock price should underperform the market by -1.02%. During that period the price should oscillate between -12.67% and +27.18%.
In the medium term (3months), ONCE's stock price should underperform the market by -2.28%. During that period the price should oscillate between -22.71% and +61.55%.Get email alerts
Create a solid portfolio with ONCE
About Spark Therapeutics, Inc.
Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA.
At the moment the company generates 65M USD in revenues.
On its last earning announcement, the company reported a loss of -2.10$ per share.
The book value per share is 15.54$
Three months stock forecastFeb. 27, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|